I

InterCure Ltd
TASE:INCR

Watchlist Manager
InterCure Ltd
TASE:INCR
Watchlist
Price: 522.3 ILS 2.94% Market Closed
Market Cap: 251.2m ILS
Have any thoughts about
InterCure Ltd?
Write Note

InterCure Ltd
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

InterCure Ltd
Operating Expenses Peer Comparison

Comparables:
TEVA
SLGL
MDWD
S
SEMG
R
REKA

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
I
InterCure Ltd
TASE:INCR
Operating Expenses
-â‚Ş74.1m
CAGR 3-Years
-2%
CAGR 5-Years
-47%
CAGR 10-Years
-24%
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Operating Expenses
-$4.6B
CAGR 3-Years
1%
CAGR 5-Years
2%
CAGR 10-Years
4%
Sol Gel Technologies Ltd
NASDAQ:SLGL
Operating Expenses
-$23.4m
CAGR 3-Years
11%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Mediwound Ltd
NASDAQ:MDWD
Operating Expenses
-$17.8m
CAGR 3-Years
1%
CAGR 5-Years
-9%
CAGR 10-Years
-3%
S
Seach Medical Group Ltd
TASE:SEMG
Operating Expenses
-â‚Ş38.2m
CAGR 3-Years
-62%
CAGR 5-Years
-56%
CAGR 10-Years
-25%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Operating Expenses
-â‚Ş57.3m
CAGR 3-Years
-6%
CAGR 5-Years
-4%
CAGR 10-Years
3%

See Also

What is InterCure Ltd's Operating Expenses?
Operating Expenses
-74.1m ILS

Based on the financial report for Dec 31, 2023, InterCure Ltd's Operating Expenses amounts to -74.1m ILS.

What is InterCure Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-24%

Over the last year, the Operating Expenses growth was 23%. The average annual Operating Expenses growth rates for InterCure Ltd have been -2% over the past three years , -47% over the past five years , and -24% over the past ten years .

Back to Top